Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1989 | |
| Sales | 18,358 |
| Cost of Goods | 8,944 |
| Gross Profit | 9,414 |
| Operating Expenses | 9,252 |
| Operating Income | 1,106 |
| Other Income | 295 |
| Pre-tax Income | 1,401 |
| Net Income Continuous | 1,401 |
| Net Income | $1,401 |
| EPS Basic Total Ops | 0.51 |
| EPS Basic Continuous Ops | 0.51 |
| EPS Diluted Total Ops | 0.51 |
| EPS Diluted Continuous Ops | 0.51 |
| EBITDA(a) | $1,844 |